A股異動 | 影視股集體上漲 2023年春節檔新片預售票房突破2億元
格隆匯1月18日丨影視股集體上漲,鼎龍文化漲停,慈文傳媒漲5%,文投控股、上海電影、光線傳媒、金逸影視漲2%,華誼兄弟、中國電影漲1%。據燈塔專業版數據實時數據,截至1月17日16時45分,2023年春節檔新片預售票房突破2億元,四部真人電影《無名》《滿江紅》《流浪地球2》《交換人生》分列前四位。中原證券表示,展望2023年,認為國內電影市場已具備復甦條件,2022年內由於各種原因未能如期上映的影片為2023年及以後的電影市場形成內容儲備,未來上映後有望帶動觀眾需求。該行預計感染高峯過後,社會面的各種娛樂活動以及消費需求將恢復,在2022年行業較低的基數上,2023年國內電影市場有望迎來較好的增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.